Glow Discharge Plasma Deposition (GDPD) Technique for the Local Controlled Delivery of Hirudin from Biomaterials
- 1 January 1998
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (5), 783-786
- https://doi.org/10.1023/a:1011987423502
Abstract
Purpose. Biomaterials which release locally high concentrations of antithrombotic agents should lessen the thrombogenicity of the materials. To evaluate this approach, we prepared novel polyurethane...Keywords
This publication has 7 references indexed in Scilit:
- The Role of Thrombin and Thrombin Inhibitors in Coronary AngioplastyChest, 1995
- Prospects for site-specific delivery of pharmacologic and molecular therapiesJournal of the American College of Cardiology, 1994
- Glow discharge plasma deposition of tetraethylene glycol dimethyl ether for fouling‐resistant biomaterial surfacesJournal of Biomedical Materials Research, 1992
- Neutralization of Recombinant Hirudin: Some Practical ConsiderationsSeminars in Thrombosis and Hemostasis, 1991
- A Fast Photometric Assay for the Determination of HirudinPathophysiology of Haemostasis and Thrombosis, 1991
- Past, Present and Future of HirudinPathophysiology of Haemostasis and Thrombosis, 1991
- Polymers for Sustained Macromolecule Release: Procedures to Fabricate Reproducible Delivery Systems and Control Release KineticsJournal of Pharmaceutical Sciences, 1980